511 related articles for article (PubMed ID: 9183235)
1. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.
Arch Intern Med; 1997 Jun; 157(11):1237-40. PubMed ID: 9183235
[TBL] [Abstract][Full Text] [Related]
2. [Atrial fibrillation and apoplexy--risks and prevention].
Koefoed BG; Gulløv AL; Petersen P
Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
[TBL] [Abstract][Full Text] [Related]
3. Atrial fibrillation and stroke. Three new studies, three remaining questions.
Albers GW
Arch Intern Med; 1994 Jul; 154(13):1443-8. PubMed ID: 8017999
[TBL] [Abstract][Full Text] [Related]
4. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
5. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
[TBL] [Abstract][Full Text] [Related]
6. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
7. Stroke prevention in atrial fibrillation.
Halperin JL; Rothlauf EB
Mt Sinai J Med; 1993 Sep; 60(4):289-94. PubMed ID: 8232372
[TBL] [Abstract][Full Text] [Related]
8. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
[TBL] [Abstract][Full Text] [Related]
9. Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial.
Hart RG; Bhatt DL; Hacke W; Fox KA; Hankey GJ; Berger PB; Hu T; Topol EJ;
Cerebrovasc Dis; 2008; 25(4):344-7. PubMed ID: 18303254
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic therapy in atrial fibrillation.
Turpie AG; Connolly SJ
Can Fam Physician; 1996 Jul; 42():1341-5. PubMed ID: 8754703
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation and atrial fibrillation.
Atwood JE; Albers GW
Herz; 1993 Feb; 18(1):27-38. PubMed ID: 8454250
[TBL] [Abstract][Full Text] [Related]
12. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials.
Albers GW; Sherman DG; Gress DR; Paulseth JE; Petersen P
Ann Neurol; 1991 Oct; 30(4):511-8. PubMed ID: 1789680
[TBL] [Abstract][Full Text] [Related]
13. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
[TBL] [Abstract][Full Text] [Related]
17. [Atrial fibrillation: embolic risk and prevention].
Rossi P
Cardiologia; 1993 Dec; 38(12 Suppl 1):319-25. PubMed ID: 8020031
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation for atrial fibrillation: epidemiology informing a difficult clinical decision.
Singer DE
Proc Assoc Am Physicians; 1996 Jan; 108(1):29-36. PubMed ID: 8834062
[TBL] [Abstract][Full Text] [Related]
19. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
Ezekowitz MD; Bridgers SL; James KE; Carliner NH; Colling CL; Gornick CC; Krause-Steinrauf H; Kurtzke JF; Nazarian SM; Radford MJ
N Engl J Med; 1992 Nov; 327(20):1406-12. PubMed ID: 1406859
[TBL] [Abstract][Full Text] [Related]
20. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
